Enabling GMP Production Of sgRNA For CRISPR-Based Cell And Gene Therapies
Source: Synthego Corporation
CRISPR technology has revolutionized the field of gene editing, enabling the development of groundbreaking cell and gene therapies. Join us to delve into the critical steps involved in bringing CRISPR-based therapeutics to market. We'll discuss:
Optimizing sgRNA Design: Learn how to select the most effective sgRNAs for your research.
Navigating the Regulatory Landscape: Understand the key regulatory considerations for CRISPR-based therapies.
Emerging Trends and Best Practices: Stay ahead of the curve with the latest advancements in CRISPR technology.
access the Webinar!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Advancing RNA? Subscribe today.
Subscribe to Advancing RNA
X
Subscribe to Advancing RNA
Synthego Corporation
This website uses cookies to ensure you get the best experience on our website. Learn more